Abstract
Respiratory tract infections (RTIs), the most common indication for outpatient antimicrobial therapy, impose a heavy medical and societal burden and present a difficult therapeutic challenge in the face of increasing pathogen resistance worldwide. Gatifloxacin is a new broad-spectrum fluoroquinolone with excellent activity against prevalent respiratory bacteria, including penicillin-resistant Streptococcus pneumoniae and atypical pathogens. A multicenter, open-label, noncomparative surveillance study carried out in Mexico evaluated the safety and efficacy of oral gatifloxacin 400 mg once daily in 17,923 adult outpatients with community-acquired pneumonia (CAP) (n = 3322), acute exacerbations of chronic bronchitis (AECB) (n = 5885), and acute bacterial sinusitis (n = 8716). Voluntary, unpaid physician participation contributed to an unbiased study design. Physician-assessed global rate of cure or improvement was 96.3%; efficacy was 95.8% in CAP, 96.1% in AECB, and 96.4% in sinusitis. The incidences of relapse (1.5%) and therapeutic failure (0.7%) were low. The most commonly reported adverse events, nausea (2.76%), headache (2.20%), and dizziness (1.33%), were generally mild and self-limited. Oral gatifloxacin 400 mg once daily i...Continue Reading
References
Dec 14, 1995·The New England Journal of Medicine·J G Bartlett, L M Mundy
Nov 1, 1993·The American Review of Respiratory Disease·M S NiedermanV L Yu
Jun 1, 1996·The Journal of Laryngology and Otology·B SenerF Tunçkanat
Jan 1, 1997·The Nurse Practitioner·S Leiner
Mar 27, 1998·Chest·P Ball, B Make
Jun 13, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J G BartlettT M File
Jun 13, 1998·International Journal of Antimicrobial Agents·M SouliG M Eliopoulos
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·J M Blondeau
Jul 27, 1999·Vaccine·H AhmanJ Eskola
Oct 26, 1999·Annals of Emergency Medicine·D A Talan
Feb 1, 2000·Respiratory Medicine·R C Read
Feb 19, 2000·Antimicrobial Agents and Chemotherapy·E Hershberger, M J Rybak
Apr 5, 2000·The Journal of Antimicrobial Chemotherapy·J Fung-TomcD Bonner
Apr 5, 2000·Seminars in Respiratory Infections·M S Niederman
Jun 10, 2000·Chest·S Sethi
Jun 13, 2000·Pharmacotherapy·F P LaCretaD M Grasela
Jul 11, 2000·Otolaryngology--head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
Sep 19, 2000·Antimicrobial Agents and Chemotherapy·A LubaschH Lode
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D J HobanR N Jones
Jun 22, 2002·Clinical Therapeutics·Mark H GotfriedRobert N Palmer
Citations
Oct 12, 2002·Diagnostic Microbiology and Infectious Disease·Lionel A Mandell
Feb 19, 2005·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Harold JensenBrian Short
Aug 21, 2002·Expert Opinion on Pharmacotherapy·Steven J MartinSandy J Close
May 29, 2004·Helicobacter·Ala I ShararaGeorge F Araj
Aug 3, 2006·Helicobacter·Ala I ShararaSouha S Kanj
May 17, 2005·Drugs·Wael E Shams, Martin E Evans